Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CO › AURORA › CORAZON T AGUILAR, MD, PC

CORAZON T AGUILAR, MD, PC

NPI: 1770604662 · AURORA, CO 80012 · Exclusive Provider Organization · NPI assigned 04/02/2007

$6.34M
Total Medicaid Paid
241,183
Total Claims
223,624
Beneficiaries
83
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialEICH, VANNEHE (OPERATIONS)
NPI Enumeration Date04/02/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 33,223 $873K
2019 39,189 $982K
2020 35,527 $829K
2021 38,401 $920K
2022 36,047 $947K
2023 36,222 $1.12M
2024 22,574 $674K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 17,769 15,966 $1.67M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 15,650 14,111 $1.01M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4,962 4,808 $461K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 4,459 4,255 $449K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4,158 4,040 $388K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3,276 3,032 $285K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 15,359 14,808 $282K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 5,179 5,002 $203K
92587 5,506 5,303 $192K
90472 Immunization administration, each additional vaccine (list separately) 6,698 6,490 $114K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1,047 1,000 $102K
96110 Developmental screening, with scoring and documentation, per standardized instrument 7,375 7,169 $98K
G8510 Screening for depression is documented as negative, a follow-up plan is not required 8,829 8,274 $95K
D0145 Oral evaluation for a patient under three years of age 2,678 2,605 $81K
90651 2,302 2,193 $79K
94760 46,134 39,637 $75K
96127 5,631 5,208 $69K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 4,504 4,201 $68K
D1206 Topical application of fluoride varnish 3,839 3,750 $64K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 5,236 4,936 $48K
80061 Lipid panel 3,304 3,129 $45K
87631 345 301 $43K
83655 2,963 2,866 $39K
94010 1,210 1,073 $36K
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 1,341 1,248 $35K
99173 3,676 3,518 $29K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,690 1,616 $26K
90460 Immunization administration through 18 years of age via any route, first or only component 1,231 1,187 $24K
90686 6,130 5,945 $21K
90734 1,085 1,068 $17K
90474 1,440 1,416 $16K
36416 9,452 8,948 $14K
85018 5,394 5,194 $13K
36415 Collection of venous blood by venipuncture 4,716 4,406 $13K
D0190 738 712 $11K
90619 466 425 $11K
90670 2,131 2,086 $11K
99381 111 108 $11K
99215 Prolong outpt/office vis 69 60 $10K
90715 773 738 $9K
81025 1,180 1,055 $9K
99000 9,919 8,999 $8K
81002 2,554 2,386 $8K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 56 49 $5K
90710 207 195 $4K
90681 1,549 1,518 $4K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 45 37 $4K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 119 105 $4K
90633 925 885 $3K
90671 295 284 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 208 176 $3K
87807 183 178 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 141 126 $2K
99383 15 15 $2K
90697 420 404 $2K
99384 13 12 $2K
90698 1,000 986 $1K
90649 143 140 $997.68
99201 29 25 $959.88
93000 54 53 $926.55
90696 174 165 $915.33
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 26 25 $903.05
90685 792 774 $634.84
90716 82 82 $371.76
96160 270 247 $263.86
90700 69 67 $137.44
90647 222 219 $100.31
90707 83 83 $93.96
90744 469 464 $86.88
A4617 Mouth piece 420 405 $67.68
87110 16 14 $64.28
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 20 18 $39.90
90461 49 49 $39.00
90656 120 118 $17.01
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 84 69 $11.02
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 12 12 $0.12
90723 111 111 $0.00
90657 92 89 $0.00
90677 13 13 $0.00
88142 14 14 $0.00
90658 105 100 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 16 13 $0.00
90687 13 13 $0.00